May 17, 2013 | fortmilltimes.com
The Prostate Cancer Foundation (PCF) today announced that it is funding two more Young Investigators (YIs) in China to lead innovative research projects within the country and expand PCF’s global knowledge exchange on...
Read more...
PCF prostate cancer China Young research EMI1 progression
May 16, 2013 | newsfix.ca
Men who drink red wine have a significantly reduced risk of developing prostate cancer, according to a new study. The benefits of moderate consumption of red wine on heart health are well known. A study from the Fred Hutchinson...
Read more...
Abigail Mellier prostate wine cancer red risk reduce flavonoids consumption
May 16, 2013 | medicaldaily.com
After finding out he had prostate cancer just last June, comedian Tommy Chong announces a cancer-free diagnosis that he claims is due to a steady regimen of hash oil. Legendary comedian and noted pot enthusiast Tommy Chong has...
Read more...
All similar articles: 131 »
cancer Chong prostate Tommy cancer-free cure marijuana hash claim Administrationor diagnosis
May 17, 2013 | sunherald.com
Psst! Is your hair -- or lack of it -- trying to tell you something? Two new reports link male pattern baldness (not that celebrity-inspired shaved noggin) with higher odds for heart disease and prostate cancer. Those aren't...
Read more...
baldness hairy Signal hair redhead health prostate artery cholesterol skin risk thyroid cancer DHT No. heart LDL
May 16, 2013 | crescent-news.com
DES MOINES, Iowa -- So you didn't win Wednesday's $360 million Powerball jackpot? Make that you and everyone else. A message early Thursday on the multistate lottery's website said the jackpot has soared to $475 million after...
Read more...
All similar articles: 638 »
Powerball jackpot soar prostate ticket winning Medicare Tavenner VA $475 million toilet device cancer sell
May 15, 2013 | streetinsider.com
FREE Breaking News Alerts from StreetInsider.com! Note: This release corresponds to ASCO abstracts 5014, 5004, 5009, 5010, 5013, 5037, 5059, 9617, 9618, 5059, 8502, 7130, 8619, 8613, 8614, 7014, 7056, 7057, 8512 and electronic...
Read more...
 ZYTIGA ibrutinib Janssen abiraterone
May 15, 2013 | finanznachrichten.de
RARITAN, N.J., May 15, 2013 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced that data related to three Janssen Oncology compounds have been selected for presentation at the 49th Annual Meeting of the...
Read more...
ibrutinib abstract 8:00am-11:45am mCRPC abiraterone castration-resistant Janssen MD Author Lead Cancer Oncology CDT Genitourinary metastatic acetate poster A2 prostate ASCO session patient USA Ph.D. pts 8:00am-12:00pm leukemia
May 16, 2013 | bayer.com
Bayer to Present New Data Across Oncology Portfolio at ASCO 2013 First presentation of final analysis from pivotal Phase III DECISION trial of Nexavar (sorafenib) in patients with differentiated thyroid cancer presented as...
Read more...
o Bayer Abstract Session Poster A2 dichloride Ra-223 III 11:45 regorafenib 8:00 REG Nexavar Cancer ALSYMPCA HealthCare phase oncology S ASCO gastrointestinal Genitourinary Hall
May 16, 2013 | firmenpresse.de
New data to be presented at the 2013 ASCO Annual Meeting show Active Biotech's commitment to oncology research (Thomson Reuters ONE) - Lund, Sweden, May 16, 2013, Active Biotech (NASDAQ OMX NORDIC: ACTI) will present data from...
Read more...
tasquinimod ANYARA Biotech ASCO Active Phase patient renal cancer study Ipsen II treatment mCRPC OS endpoint Meeting
May 15, 2013 | prweb.com
Neal Shore, MD, Medical Director, Carolina Urologic Research Center, Myrtle Beach, SC, presented on Vaccine Therapy and Immunotherapy. Daniel Petrylak, MD, Leader, Prostate Medical Oncology at the... (PRWeb May 14, 2013) Read...
Read more...
Audio-Digest urology MD Medical Cancer Medicine 36 Petrylak Center Malignancies Genitourinary Urologic
May 15, 2013 | medicalphysicsweb.org
LYON, FRANCE, 14 May 2013 – EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, highlighted its positive reception at the American Urological Association (AUA) 2013 Annual Meeting, held in San Diego on May...
Read more...
HIFU Ablatherm-HIFU EDAP prostate Urology AUA poster Meeting treatment cancer Sonolith TMS localized Chaussy Society
May 16, 2013 | medicalphysicsweb.org
Photoacoustic imaging can be successfully applied to diagnose prostate cancer – with greater accuracy than the current preferred method, transrectal ultrasound guided biopsy – according to researchers from the US....
Read more...
Photoacoustic prostate transrectal imaging ultrasound cancer Dogra biopsy sample tissue method image
May 15, 2013 | medicalxpress.com
In the largest clinical trial to date to examine the efficacy of PARP inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be effective against advanced...
Read more...
All similar articles: 431 »
patient cancer olaparib pancreatic BRCA PARP prostate mutation inhibitor BRCA2 ovarian BRCA1 percent study therapy
May 15, 2013 | dailyfinance.com
Filed under: Investing Reminder: Cabozantinib to be Featured in Nine Presentations at the 2013 ASCO Annual Meeting -- Exelixis to host investor briefing via live webcast on Sunday, June 2, 2013 SOUTH SAN FRANCISCO, Calif.--(...
Read more...
cabozantinib 8:00-11:45 ASCO Cancer Exelixis Poster Meeting Presentations Abstract Genitourinary Annual Session A2 2013 subsession Featured metastatic Nine NCI-CTEP
May 15, 2013 | yahoo.com
Marketwired] - IsoRay, Inc. , a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for brain cancer, lung cancer, head and neck cancer, prostate cancer and gynecologic ...
Read more...
IsoRay cancer Cesium-131 Cs-131 prostate brachytherapy quarter Cesium
May 16, 2013 | finanznachrichten.de
Lund, Sweden, 2013-05-16 08:50 CEST (GLOBE NEWSWIRE) -- Lund, Sweden, May 16, 2013, EXINI Diagnostics AB (publ), listed on NASDAQ OMX First North and Active Biotech (NASDAQ OMX NORDIC: ACTI) will p...
Read more...
Globenewswire EXINI Diagnostics BSI AB Biotech tasquinimod Active cancer
May 15, 2013 | medscape.com
A novel radiopharmaceutical that emits alpha radiation improves survival in men with castration-resistant prostate cancer that has metastasized to bone. FDA Approvals (Source: Medscape Today Headlines) MedWorm Sponsor Message:...
Read more...
All similar articles: 98 »
Medscape clinical drug&disease medical CME Smartphone Reference CE Complete
May 15, 2013 | marketwire.com
28% Increase in Third Quarter Revenues Over Second Quarter RICHLAND, WA--(Marketwired - May 15, 2013) - IsoRay , Inc. , a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for...
Read more...
IsoRay cancer Cesium-131 Cs-131 prostate brachytherapy quarter Cesium
May 15, 2013 | finance.yahoo.com
Recently, Genomic Health Inc. made available its lead pipeline candidate Oncotype DX prostate cancer test to physicians and their patients. This comes as a major boost to the company as its effort to launch the test by the...
Read more...
Genomic prostate test cancer Oncotype DX launch patient treatment clinical
May 16, 2013 | finanznachrichten.de
Not Intended for US Media Oslo, Norway, 16 May 2013 - Algeta ASA (OSE: ALGETA) announces that further analyses of data subsets from the phase III ALSYMPCA study of the recently FDA-approved Xofigo® (radium 223 dichloride,...
Read more...
Thomson Algeta radium Xofigo radium-223 223 dichloride ASA Ra-223 ALSYMPCA metastasis bone CRPC Bayer
May 15, 2013 | macreportmedia.com
28% Increase in Third Quarter Revenues Over Second Quarter RICHLAND, WA-- May 15, 2013 - ), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for brain cancer, lung cancer,...
Read more...
IsoRay cancer Cs-131 prostate quarter Cesium lung gyn brachytherapy
May 16, 2013 | investegate.co.uk
Algeta ASA : New data and analyses from clinica... Not Intended for US Media Oslo, Norway, 16 May 2013 - Algeta ASA (OSE: ALGETA) announces that further analyses of data subsets from the phase III ALSYMPCA study of the recently...
Read more...
Algeta radium ASA 223 dichloride clinica Ra-223 ALSYMPCA metastasis Xofigo bone CRPC radium-223 Bayer
May 15, 2013 | natures-health-foods.com
Omega 3's Fish-Oil ~ Super Food Remedies Fish-Oil ~ Healing Foods As many of our long time readers know, Marilyn and I are big advocates of adding fish and more specifically, Omega-3's to our diets. A woman’s risk of getting...
Read more...
omega-3 fish-oil DHA omega-6 Bailes fish EPA brain nutrient McGeehin McCloy inflammation omega DRI
May 15, 2013 | birminghamstar.com
Martin Williams, CEO, Tokai Pharmaceuticals Cambridge biopharma Tokai Pharmaceuticals Inc. has raised a $35.5M Series E round of funding led by current investors and undisclosed angel investors. The round of funding, which...
Read more...
$35.5M Tokai prostate Pharmaceuticals galeterone ARMOR2 cancer treatment advance raise Tokais
May 15, 2013 | wakingtimes.com
Waking Times Last June, the famous comedian, actor and pro-marijuana legalization advocate, Tommy Chong, reported to the world that he had been diagnosed with stage 1 prostate cancer and that he was seeking unconventional...
Read more...
Dylan Charles cancer Tommy Chong hemp diet prostate Cannabis treatment oil proper google www.cancer.org legalization
May 14, 2013 | yahoo.com
May 14 2013, 10:57 by: Suresh Gupta | includes: The problem with cancer treatment that makes it truly a scourge is differentiating cancer cells from healthy cells. The immune system can't do it and doesn't attack tumors as it...
Read more...
Suresh Gupta electroporation Nanoknife Phase cancer trial cell ANGO OncoSec II immune tumor Inovio Angiodynamics CROES VU melanoma
May 15, 2013 | prweb.com
Neal Shore, MD, Medical Director, Carolina Urologic Research Center, Myrtle Beach, SC, presented on Vaccine Therapy and Immunotherapy. Daniel Petrylak, MD, Leader, Prostate Medical Oncology at the Yale Cancer Center, New Haven,...
Read more...
Audio-Digest prostate urology MD 05 Medical cancer Medicine 36 Petrylak Center Malignancies Genitourinary Urologic
May 14, 2013 | itechpost.com
Photomicrograph of invasive Prostate Adenocarcinoma http://cgap-mf.nih.gov/images/CGAP55_2_L_Pr10.jpg from http://cgap-mf.nih.gov/ProstateExample/ProstateMAandResults/Histology/Pr10.html Credit:US Government work; Public domain...
Read more...
prostate cancer statins statin study non-statin cholesterol cgap-mf.nih.gov risk
May 14, 2013 | freshbestarticles.com
HIFU or High Intensity Focused Ultrasound refers to a medical procedure that is highly precise where high-intensity focused sonic energy is applied to locally heat and destroy damaged or diseased tissue by ablation. During this...
Read more...
HIFU tissue procedure treatment therapy ultrasound cancer ablation tumor used to prostate fibroids clinical focused focussed hifucare.com MRgHIFU treat temperature
May 15, 2013 | prostate.net
Sipuleucel-T for Prostate Cancer Sipuleucel-T for prostate cancer was approved by the Food and Drug Administration in April 2010. Marketed under the name PROVENGE and made by the Dendreon Corporation, sipuleucel-T is indicated...
Read more...
Sipuleucel-T prostate cancer immunotherapy